2001-June Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Fri Jun 1 07:26:01 2001
Ending: Sat Jun 30 13:59:01 2001
Messages: 126

• [Pharm-policy] Contracting out research   love@cptech.org
• [Pharm-policy] Global Fund: Mostly Bad News from UNAIDS PCB Meeting   Paul Davis
• [Pharm-policy] Hague Convention: what you should know   James Love
• [Pharm-policy] FW: Sources and Prices of selected drugs and diagnostics   Paul Davis
• [Pharm-policy] Pharma lobbying figures from the Center for Responsive Politics   Mike Palmedo
• [Pharm-policy] SA press resease on Medicines Control Act   Mike Palmedo
• [Pharm-policy] re: FW: FT on Global Fund: Prevention not Treatment   Paul Davis
• [Pharm-policy] FW: Pfizer PR   Paul Davis
  • [Pharm-policy] Re: [Ip-health] FW: Pfizer PR   Alan Story
• [Pharm-policy] [MediaChannel] AIDS Coverage For 20 Years (fwd)   Fil
• [Pharm-policy] Henry Hyde Bill ($469M to USAID)   Mike Palmedo
• [Pharm-policy] Hyde Press Releae   Paul Davis
• [Pharm-policy] (no subject)   Alacran7@aol.com
• [Pharm-policy] Top USAID official decides that millions will die.   Paul Davis
• [Pharm-policy] (no subject)   Samuel.George@LW.com
  • [Pharm-policy] Re:   Alan Story
• [Pharm-policy] Debunking Natzios' simple racist claims on behalf of phamcos   Paul Davis
• [Pharm-policy] Richter defeats Pfizer appeal   Mike Palmedo
• [Pharm-policy] Natsios fact check   Paul Davis
• [Pharm-policy] BMS Dupont deal   love@cptech.org
• [Pharm-policy] FDA to Stop All Mail Imports   James Love
• [Pharm-policy] Partners - Press Release   James Love
• [Pharm-policy] life   George M. Carter
• [Pharm-policy] Melody Peterson on counterfeiting in USA   love@cptech.org
  • [Pharm-policy] Melody Peterson on counterfeiting in USA   James Love
• [Pharm-policy] Kenyan parliament opens debate on AIDS drugs   love@cptech.org
• [Pharm-policy] Novartis sues over Glaxo evergreening patents on Augmentin   love@cptech.org
• [Pharm-policy] Lawsuit over Schering conspiracy to block generic K-Dur20   love@cptech.org
• [Pharm-policy] South Africa proposes new parallel import regs, but no new complusory licensing proceedures   James Love
• [Pharm-policy] IMS Health   love@cptech.org
• [Pharm-policy] LA Times on class action suits against pharma firms   love@cptech.org
• [Pharm-policy] FW: NEWS: Natsios called racist; firing sought (Boston Globe)   Paul Davis
• [Pharm-policy] Gemstar-TV Guide compulsory licensing case   love@cptech.org
• [Pharm-policy] Pink Sheet charges IMS with copyright infringement   love@cptech.org
• [Pharm-policy] Re : [Ip-health] Melody Peterson on counterfeiting in USA   Khalil Elouardighi
• [Pharm-policy] RE: Re : [Ip-health] Melody Peterson on counterfeiting in USA   Tate Heuer
• [Pharm-policy] Re: Re : [Ip-health] Melody Peterson on counterfeiting in USA   Dean Baker
• [Pharm-policy] Re: [j2000-grassroots] FW: NEWS: Natsios called racist; firing sought (Boston...   SDANSOKHO@aol.com
• [Pharm-policy] Reuters: Kenya's Parliament Passes AIDS Drugs Bill   Mike Palmedo
• [Pharm-policy] Families USA report   Mike Palmedo
• [Pharm-policy] Pfizer obtains injunction against Cadila on Penegra   Mike Palmedo
• [Pharm-policy] June 23 is for you and everyone.   Paul Davis
• [Pharm-policy] ACT UP wants to talk to you.   Paul Davis
• [Pharm-policy] Re: Pharm-policy digest, Vol 1 #404 - 2 msgs   Alacran7@aol.com
• [Pharm-policy] Brookings: "A Patent Policy Proposal for Global Disease   Mike Palmedo
• [Pharm-policy] From the Washington Post   Gonsalves, Gregg
• [Pharm-policy] Canada Supreme court to rule on patent for Harvard Mouse   love@cptech.org
• [Pharm-policy] Dr. Reddy licensing of drugs to Novartis and Novo Nordisk   love@cptech.org
• [Pharm-policy] Malaysia: Price list of drugs to go online   love@cptech.org
• [Pharm-policy] Kenyan AIDS orphans take generic anti-retrovirals   love@cptech.org
• [Pharm-policy] the Hindu on MSF/National Working Group on Patents Delhi meeting   love@cptech.org
• [Pharm-policy] Traffic on list   James Love
• [Pharm-policy] Reuters on the Partners Meeting in Cochin, India   James Love
• [Pharm-policy] Mobile phone =?iso-8859-1?Q?companies=92?= patenting of cancer shields sparks debate (issue 28)   love@cptech.org
• [Pharm-policy] More Stories from the EU's IP WIRE Newsletter Issue 28   James Love
• [Pharm-policy] FW: Washington Post: (Op-ed) Cure for a Chronic Dilemma   Paul Davis
• [Pharm-policy] US pushes Korea on data protection   love@cptech.org
• [Pharm-policy] Korea, also drug registration linked patents   James Love
• [Pharm-policy] NY Newsday: Good article on the global fund   Paul Davis
• [Pharm-policy] (updated info) Dying from Lack of Treatment   David_VEAZEY@amsterdam.msf.org
• [Pharm-policy] Far Eastern Economic Review on Malaysian/US effort on HIV drug   James Love
• [Pharm-policy] Observer: US bad, EU good, in access to medicine trade dispute   love@cptech.org
• [Pharm-policy] EU seeks broader parallel import rights for DVDs   love@cptech.org
• [Pharm-policy] Karen DeYoung: AIDS in the Caribbean   love@cptech.org
• [Pharm-policy] EU position on TRIPs and Access   James Love
• [Pharm-policy] WIPO and WTO to "help" world's poorest countries with TRIPS   love@cptech.org
• [Pharm-policy] WTO on Bolar, Compulsory Licensing, and Parallel Imports   love@cptech.org
• [Pharm-policy] Christian Science Monitor on Corporate/University collaborations   love@cptech.org
• [Pharm-policy] Hoffman La-Roche: Dumping Old Meds on Africa   James Love
• [Pharm-policy] US Statement at yesterday's TRIPS council meeting   James Love
• [Pharm-policy] Partners Cochin meeting, report of IPR and trade working group   James Love
• [Pharm-policy] TRIPS Council - developing countries paper   James Love
• [Pharm-policy] Kochi Declaration on Accelerating Essential Health Commodity Security through South to South Collaboration   James Love
• [Pharm-policy] MSF report on TRIPS Council on access to medicines   James Love
• [Pharm-policy] Ralph Nader questions Peter Dolan (BMS chair) patriotism for high US drug prices   James Love
• [Pharm-policy] Observer article and Lanjouw Paper   Dwijen Rangnekar
• [Pharm-policy] Pharma PAC Spending figures for two election cycles   Mike Palmedo
• [Pharm-policy] Petersen in NYT on bulk purchasing, and what are the real policy choices for the HIV Fund?   love@cptech.org
• [Pharm-policy] Petersen in NYT on bulk purchasing, and what are the real policy choices for the HIV Fund?   love@cptech.org
• [Pharm-policy] Jayson Blair: Woman Wins Suit on Misleading AIDS Ad   love@cptech.org
• [Pharm-policy] WTO ruling on illegal US tax breaks   love@cptech.org
• [Pharm-policy] Patent on "Winter II" antibody expression library   love@cptech.org
• [Pharm-policy] Exxon Unocal compulsory licensing dispute   love@cptech.org
• [Pharm-policy] WTO to release checklist on Drug Patents by July 25   love@cptech.org
• [Pharm-policy] FTC Charges Hearst Trust with Acquiring Monopoly In Vital Drug Information Market   love@cptech.org
• [Pharm-policy] CAT press release on Winter II patent   love@cptech.org
• [Pharm-policy] Dawn on WTO TRIPS Council meeting   love@cptech.org
• [Pharm-policy] Dallas Morning News on Generic evergreening strategies   love@cptech.org
• [Pharm-policy] TWN Report: TRIPS Drugs session 20 June   James Love
• [Pharm-policy] Salon: AIDS activists change their act   James Love
• [Pharm-policy] Has Brazil issued a compulsory license??   Dwijen Rangnekar
• [Pharm-policy] Poverty No Obstacle to AIDS Treatment, Experts Say   Gregg Gonsalves
• [Pharm-policy] NEW CornerHouse briefing (Mail 15): WTO, services and health   Dwijen Rangnekar
• [Pharm-policy] [Fwd: [Ip-health] US drops case against Brazil]   Mike Palmedo
• [Pharm-policy] Brazil-US Joint Communication: WTO Panel on patent   James Love
• [Pharm-policy] USTR press release on Brazil WTO case   James Love
• [Pharm-policy] Article 68 of Brazil patent law   love@cptech.org
• [Pharm-policy] CPT and Robert Weissman comments on Brazil case   James Love
• [Pharm-policy] USTR clarifies scope of consultation on compulsory licenses   James Love
• [Pharm-policy] Tanzanian Company Vows to Produce Anti-AIDS Drugs   James Love
• [Pharm-policy] Problems with the PhRMA Compulsory License Argument   Nathan Geffen
• [Pharm-policy] Excerpt from BNA story on US/Brazil WTO case   Mike Palmedo
• [Pharm-policy] Gay Men's Health Crisis Statement on Boehringer-Ingelheim and Nev irapine for the Prevention of Mother-to-Child Transmission of HIV   Gonsalves, Gregg
• [Pharm-policy] Brazil compulsory licensing effort for Viracept   love@cptech.org
• [Pharm-policy] Salon on UNGASS   love@cptech.org
• [Pharm-policy] Raul Cesan resigns as CEO of Schering   James Love
• [Pharm-policy] Raul Cesan's stock options   love@cptech.org
• [Pharm-policy] House Release on new AIDS money   Mike Palmedo
• [Pharm-policy] Prices of Glucphage (Metformin hydrochlor) in US and UK   James Love
  • [Pharm-policy] Make that Glucophage (Metformin Hydrochloride)   James Love
• [Pharm-policy] Top 200 Brand-Name Drugs By Retail Sales In 2000   love@cptech.org
• [Pharm-policy] UN Declaration of Commitment on HIV/AIDS   Mike Palmedo
• [Pharm-policy] Government funded studies of Metformin   love@cptech.org
• [Pharm-policy] BMS NIDDKD (NIH) Collaboration on Glucophage research and development   love@cptech.org
• [Pharm-policy] Ontario Brand/Generic Price Comparisons for Top 25 Genericized Products(2001)   love@cptech.org
• [Pharm-policy] The Pope and Intellectual Property   Gonsalves, Gregg
  • [Pharm-policy] Re: [Ip-health] The Pope and Intellectual Property   Prof. Michael H. Davis
• [Pharm-policy] Bruce Beale on Glucophage   James Love
• [Pharm-policy] Florida Cancer Patient's Suit   Dean Hughson
• [Pharm-policy] Inter Press: Too Little, Too Late' Global AIDS Fund Falls Far Short of Target   Paul Davis
  • [Pharm-policy] Windfalls are never too little nor too late!   Prof. Michael H. Davis
• [Pharm-policy] Intellectual Property Rights and Microsoft Antitrust case   James Love
• [Pharm-policy] URGENT: S. Korean Call for Solidarity on Access to Medicine   Paul Davis
  • [Pharm-policy] About the Global Alliance for TB Drug Development   JOELLE TANGUY
• [Pharm-policy] =?utf-8?Q?Query_regard=C4=B1ng_the_Pharmaceut=C4=B1cal_Trans=C4=B1t=C4=B1o?= =?utf-8?Q?nal_Per=C4=B1ods.?=   IPEK EREN
• [Pharm-policy] the un outcome   Michelle Oser

Last message date: Sat Jun 30 13:59:01 2001
Archived on: Sat Jun 30 12:59:01 2001

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...